May 26, 2020
Monte Rosa Therapeutics Discloses $32.5 Million Financing
Launched from Versant’s Ridgeline Discovery Engine Based on work from Rajesh Chopra, Ian Collins and Nicolas Thomä, leaders in ubiquitin…
Pharmaceuticals, Biotechnology and Life Sciences
Launched from Versant’s Ridgeline Discovery Engine Based on work from Rajesh Chopra, Ian Collins and Nicolas Thomä, leaders in ubiquitin…
— FDA Sets PDUFA Goal Date of October 30, 2020 — WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company…
— FDA Sets PDUFA Goal Date of October 30, 2020 — WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company…
— FDA Sets PDUFA Goal Date of October 30, 2020 — WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ribon Therapeutics, a clinical stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced that Victoria…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ribon Therapeutics, a clinical stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced that Victoria…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ribon Therapeutics, a clinical stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced that Victoria…
— PDUFA Date Set for December 3, 2020 — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…
— PDUFA Date Set for December 3, 2020 — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…
— PDUFA Date Set for December 3, 2020 — CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…